Omega Diagnostics Group PLC
ODX.L · LSE
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Market Cap | £0 | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | -£0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | -£0 | £0 | £0 | £0 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | -11.6% | -2.2% | -11% | – |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 47% | 59.7% | 51% | 64.1% |
| EBITDA | -£0 | £0 | -£0 | -£0 |
| % Margin | -35.1% | 4.2% | -27.9% | -70.2% |
| Net Income | -£0 | -£0 | -£0 | -£0 |
| % Margin | -51.2% | -16.5% | -24.1% | -69.5% |
| EPS Diluted | -0.017 | -0.008 | -0.012 | -0.048 |
| % Growth | -121.3% | 37% | 75.3% | – |
| Operating Cash Flow | -£0 | -£0 | -£0 | £0 |
| Capital Expenditures | -£0 | -£0 | -£0 | -£0 |
| Free Cash Flow | -£0 | -£0 | -£0 | -£0 |